AI
Sunday, May 01, 2022 8:34:47 AM
Shareholders with real money (not lunch money) that vanished like magic under the Big Top certainly are not confused. The Clown Team has a remarkable ability to waste money and time. Thus, I'll remind any confused shareholders the very last so-called clinical trial @ AlgernonPharma (AP) was launched back in July of 2020 and still pending a 20 patient data readout.
The 1st truly powered for stat sig "Everybody Wants In @ Phase 2" clinical trial will likely not conclude until 2025 or 2026. In such time, I expect AP to follow the same path as Xortx. Moreau had already signalled he plans to follow in Xortx footsteps. Moreau hired their former CEO (sheesh). Look at Xortx pathetic performance since uplisting to Nasdaq - Market Cap: 17M USD
Yet another losing strategy @ AlgernonPharma
M$
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
